Literature DB >> 32060838

Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Yi Shen1, Harvey Risch2, Lingeng Lu2, Xiaomei Ma2, Melinda L Irwin2, Joseph K Lim3, Tamar Taddei3, Karen Pawlish4, Antoinette Stroup5, Robert Brown6, Zhanwei Wang1, Wei Jia1, Linda Wong1, Susan T Mayne7, Herbert Yu8.   

Abstract

PURPOSE: HCC incidence has been continuously rising in the US for the past 30 years. To understand the increase in HCC risk, we conducted a case-control study in Connecticut, New Jersey and part of New York City.
METHODS: Through rapid case ascertainment and random digit dialing, we recruited 673 incident HCC patients and 1,166 controls. Information on demographic and anthropometric characteristics, lifestyle factors, medical and family cancer histories, were ascertained through telephone interviews using a structured questionnaire. Saliva specimens were collected for testing hepatitis C virus (HCV) antibodies. Unconditional logistic regression models were utilized to calculate odds ratio (OR) and 95% confidence interval (CI) to determine HCC associations with risk factors.
RESULTS: The study confirmed that HCV infection and obesity were important risk factors for HCC, ORs 110 (95% CI 59.2-204) and 2.13 (95% CI 1.52-3.00), respectively. High BMI and HCV infection had synergy in association with elevated HCC risk. Patients both obese and infected with HCV had HCC detected on average nearly 10 years earlier than those with neither factor. Diabetes, cigarette smoking and heavy alcohol intake were all associated with increased risk of HCC, whereas aspirin and other NSAID use were associated with reduced risk. HCC cases tended to attain less education, with lower household incomes, unmarried, and to have had more sexual partners than the controls.
CONCLUSIONS: Individuals at risk of HCC in the US comprise a unique population with low socioeconomic status and unhealthy lifestyle choices. Given the multifactorial nature, a comprehensive approach is needed in HCC prevention.

Entities:  

Keywords:  HCC; HCV; Obesity; Risk factors

Mesh:

Year:  2020        PMID: 32060838      PMCID: PMC7136513          DOI: 10.1007/s10552-020-01277-1

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  50 in total

1.  A prospective study of obesity and cancer risk (Sweden).

Authors:  A Wolk; G Gridley; M Svensson; O Nyrén; J K McLaughlin; J F Fraumeni; H O Adam
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

2.  NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.

Authors:  Jessica L Petrick; Vikrant V Sahasrabuddhe; Andrew T Chan; Michael C Alavanja; Laura E Beane-Freeman; Julie E Buring; Jie Chen; Dawn Q Chong; Neal D Freedman; Charles S Fuchs; John Michael Gaziano; Edward Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lifang Hou; Eric J Jacobs; Lindsay Y King; Jill Koshiol; I-Min Lee; Martha S Linet; Julie R Palmer; Mark P Purdue; Lynn Rosenberg; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Peter T Campbell; Katherine A McGlynn
Journal:  Cancer Prev Res (Phila)       Date:  2015-09-21

Review 3.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

4.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

5.  Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.

Authors:  Ali H Mokdad; Laura Dwyer-Lindgren; Christina Fitzmaurice; Rebecca W Stubbs; Amelia Bertozzi-Villa; Chloe Morozoff; Raghid Charara; Christine Allen; Mohsen Naghavi; Christopher J L Murray
Journal:  JAMA       Date:  2017-01-24       Impact factor: 56.272

6.  Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.

Authors:  Oxana V Makarova-Rusher; Sean F Altekruse; Tim S McNeel; Susanna Ulahannan; Austin G Duffy; Barry I Graubard; Tim F Greten; Katherine A McGlynn
Journal:  Cancer       Date:  2016-03-21       Impact factor: 6.860

7.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Thomas Tran; James E Everhart
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 8.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.

Authors:  Hashem B El-Serag; Howard Hampel; Fariba Javadi
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

Review 9.  Obesity-associated mechanisms of hepatocarcinogenesis.

Authors:  Raffi Karagozian; Zoltán Derdák; György Baffy
Journal:  Metabolism       Date:  2014-02-05       Impact factor: 8.694

10.  Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.

Authors:  Joanna K Dowman; Laurence J Hopkins; Gary M Reynolds; Nikolaos Nikolaou; Matthew J Armstrong; Jean C Shaw; Diarmaid D Houlihan; Patricia F Lalor; Jeremy W Tomlinson; Stefan G Hübscher; Philip N Newsome
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

View more
  10 in total

1.  Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland.

Authors:  Tadeusz Wojciech Łapiński; Aleksandr Tarasik; Marcin Januszkiewicz; Robert Flisiak
Journal:  Clin Exp Hepatol       Date:  2021-03-25

Review 2.  Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?

Authors:  Myung Ji Goh; Dong Hyun Sinn
Journal:  Clin Mol Hepatol       Date:  2022-01-13

3.  Oral Cyanobacteria and Hepatocellular Carcinoma.

Authors:  Brenda Y Hernandez; Xuemei Zhu; Harvey A Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar H Taddei; Karen S Pawlish; Antoinette M Stroup; Robert Brown; Zhanwei Wang; Linda L Wong; Herbert Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10-25       Impact factor: 4.090

4.  Safety and efficacy of pharmacologic weight loss in patients with cirrhosis.

Authors:  Ali Y Fakhreddine; Samantha Bagsic; Ken Fujioka; Catherine T Frenette
Journal:  Obes Sci Pract       Date:  2020-12-02

5.  Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

Authors:  Zoe N Memel; Ashwini Arvind; Oluwatoba Moninuola; Lisa Philpotts; Raymond T Chung; Kathleen E Corey; Tracey G Simon
Journal:  Hepatol Commun       Date:  2020-11-13

6.  Association between socioeconomic status and survival in patients with hepatocellular carcinoma.

Authors:  Yongshun Zheng; Xun Zhang; Jinsen Lu; Shuchen Liu; Yeben Qian
Journal:  Cancer Med       Date:  2021-08-20       Impact factor: 4.452

7.  Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning Approach.

Authors:  Tushar Patel; Samuel O Antwi; Jonathan Thomas; Linda M Liao; Rashmi Sinha
Journal:  J Hepatocell Carcinoma       Date:  2022-02-15

Review 8.  Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma.

Authors:  Xueliang Zhou; Tengfei Zhang; Yali Sun; Chunwei Li; Xianfei Ding; Yanhui Zhu; Lifeng Li; Zhirui Fan
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

9.  Gold-based nanoparticles realize photothermal and photodynamic synergistic treatment of liver cancer and improve the anaerobic tumor microenvironment under near-infrared light.

Authors:  Bei Li; Yi Fu; Maodi Xie; Lei Feng; Xiaoya Niu; Lin Que; Zhen You
Journal:  Front Bioeng Biotechnol       Date:  2022-08-17

10.  Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study.

Authors:  Zhanwei Wang; Anuradha S Budhu; Yi Shen; Linda Lou Wong; Brenda Y Hernandez; Maarit Tiirikainen; Xiaomei Ma; Melinda L Irwin; Lingeng Lu; Hongyu Zhao; Joseph K Lim; Tamar Taddei; Lopa Mishra; Karen Pawlish; Antoinette Stroup; Robert Brown; Mindie H Nguyen; Jill Koshiol; Maria O Hernandez; Marshonna Forgues; Hwai-I Yang; Mei-Hsuan Lee; Yu-Han Huang; Motoki Iwasaki; Atsushi Goto; Shiori Suzuki; Koichi Matsuda; Chizu Tanikawa; Yoichiro Kamatani; Dean Mann; Maria Guarnera; Kirti Shetty; Claire E Thomas; Jian-Min Yuan; Chiea Chuen Khor; Woon-Puay Koh; Harvey Risch; Xin Wei Wang; Herbert Yu
Journal:  JGH Open       Date:  2021-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.